pattern

DOMENIC J. VENEZIANO is an Independent FDA Regulatory and Strategic Consultant to Sandler, Travis & Rosenberg, P.A.

Mr. Veneziano provides advice on the importation of all Food and Drug Administration-regulated commodities and the resolution of problems that may occur. He also evaluates medical device and food facilities to determine compliance with good manufacturing practice regulations and the Food Safety Modernization Act, and he assists clients in correcting any deviations found during FDA inspections or third-party audits. 

Mr. Veneziano served as director of the FDA’s Division of Import Operations for more than ten years. In that role he was responsible for oversight of FDA’s import operations program and provided leadership, guidance, and direction to approximately 1,000 field investigators in more than 320 U.S. ports of entry. He also served as co-lead in the development of the FSMA import regulations and was senior advisor on the implementation of FSMA and the FDA Safety and Innovation Act. He represented FDA on the Automated Commercial Environment/International Trade Data System board of directors and the Border Interagency Executive Council and was responsible for ensuring that all FDA and U.S. Customs and Border Protection systems such as PREDICT and ACE met all operational needs.

Mr. Veneziano began his FDA career in 1992 as a field investigator in the New England District specializing in medical device inspections. In 1998 he became a supervisory investigator in New England overseeing the medical device and import programs and in 2003 he established, staffed, and directed the Prior Notice Center, FDA’s first 24/7/365 operational office.

Mr. Veneziano holds a B.S. in engineering from the University of Maine.

 

Domenic Veneziano is not admitted to the practice of law.

Education
  • University of Maine B.S., engineering
Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.